| Craig A Lash, MD | |
|
2830 Crescent Ave, Eugene, OR 97408-7397 | |
| (541) 686-9000 | |
| (541) 242-4585 |
| Full Name | Craig A Lash |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 2830 Crescent Ave, Eugene, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235128471 | NPI | - | NPPES |
| 500630055 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD152944 (Oregon) | Primary |
| Entity Name | Mckenzie Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316909054 PECOS PAC ID: 1254307994 Enrollment ID: O20040903000766 |
News Archive
Pharmaceutical giant Pfizer has announced its intention to stop research and development in areas including Alzheimer's disease and Parkinson's disease.
Researchers have conducted clinical trials with a new drug targeting pancreatic cancer and the initial results are promising.
The uncontrolled growth of cancer cells arises from their ability to hijack the cell's normal growth program and checkpoints. Usually after therapy, a second cancer-signaling pathway will open after the primary one shuts down — creating an ingenious escape route for the cancer cell to survive. The answer, say Case Western Reserve researchers, is to anticipate and block that back-up track by prescribing two drugs from the start.
EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its review period for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS) by three months to February 28, 2011.
"In an attempt to assess the impact of U.S. international assistance for AIDS, researchers from Stanford University carried out a review of the relationship between U.S. support provided through the President's Emergency Plan for AIDS Relief (PEPFAR) and adult mortality in PEPFAR focus countries in sub-Saharan Africa, and whether there were differences in outcome between these countries and other African countries which did not receive PEPFAR support," NAM's Aidsmap reports.
› Verified 2 days ago
| Entity Name | Oregon Healthcare Resources Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982907572 PECOS PAC ID: 4486835477 Enrollment ID: O20110223001220 |
News Archive
Pharmaceutical giant Pfizer has announced its intention to stop research and development in areas including Alzheimer's disease and Parkinson's disease.
Researchers have conducted clinical trials with a new drug targeting pancreatic cancer and the initial results are promising.
The uncontrolled growth of cancer cells arises from their ability to hijack the cell's normal growth program and checkpoints. Usually after therapy, a second cancer-signaling pathway will open after the primary one shuts down — creating an ingenious escape route for the cancer cell to survive. The answer, say Case Western Reserve researchers, is to anticipate and block that back-up track by prescribing two drugs from the start.
EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its review period for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS) by three months to February 28, 2011.
"In an attempt to assess the impact of U.S. international assistance for AIDS, researchers from Stanford University carried out a review of the relationship between U.S. support provided through the President's Emergency Plan for AIDS Relief (PEPFAR) and adult mortality in PEPFAR focus countries in sub-Saharan Africa, and whether there were differences in outcome between these countries and other African countries which did not receive PEPFAR support," NAM's Aidsmap reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Craig A Lash, MD Po Box 1648, Eugene, OR 97440-1648 Ph: (541) 686-9000 | Craig A Lash, MD 2830 Crescent Ave, Eugene, OR 97408-7397 Ph: (541) 686-9000 |
News Archive
Pharmaceutical giant Pfizer has announced its intention to stop research and development in areas including Alzheimer's disease and Parkinson's disease.
Researchers have conducted clinical trials with a new drug targeting pancreatic cancer and the initial results are promising.
The uncontrolled growth of cancer cells arises from their ability to hijack the cell's normal growth program and checkpoints. Usually after therapy, a second cancer-signaling pathway will open after the primary one shuts down — creating an ingenious escape route for the cancer cell to survive. The answer, say Case Western Reserve researchers, is to anticipate and block that back-up track by prescribing two drugs from the start.
EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its review period for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS) by three months to February 28, 2011.
"In an attempt to assess the impact of U.S. international assistance for AIDS, researchers from Stanford University carried out a review of the relationship between U.S. support provided through the President's Emergency Plan for AIDS Relief (PEPFAR) and adult mortality in PEPFAR focus countries in sub-Saharan Africa, and whether there were differences in outcome between these countries and other African countries which did not receive PEPFAR support," NAM's Aidsmap reports.
› Verified 2 days ago
Bruce S Strimling, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4135 Quest Dr, Eugene, OR 97402 Phone: 541-461-8006 Fax: 541-463-2197 | |
Dr. Nicole Maria-phyllis Hauck, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 151 W 7th Ave, Suite 100, Eugene, OR 97401 Phone: 541-682-3550 | |
Dr. William David Lux, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 Hilyard St, Suite 440, Eugene, OR 97401 Phone: 541-687-9061 Fax: 541-687-6067 | |
David Scott Miller, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 995 Willagillespie Rd, Ste 200, Eugene, OR 97401 Phone: 541-341-3717 Fax: 541-302-8107 | |
Karen Weiner, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1650 Chambers St, Eugene, OR 97402 Phone: 541-338-7787 Fax: 541-684-3077 | |
Larry George Fickenscher, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: University Of Oregon Student Health Center, 1590 East 13th Avenue, Eugene, OR 97403 Phone: 541-346-4447 Fax: 541-346-2747 | |
Dr. Kevin P. Marks, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4010 Aerial Way, Eugene, OR 97402 Phone: 541-242-8500 Fax: 541-242-8491 |